XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Cash flows from operating activities:    
Net income $ 128,237 $ 269,664
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 77,529 77,985
Non-cash lease expense 143,036 144,347
Provision (benefit) for deferred income taxes 366 (5,086)
Share-based compensation expense 21,971 19,068
Store Impairment 958 0
Loss on disposition of property and equipment, net 345 193
Changes in assets and liabilities:    
Receivables (19,235) (24,387)
Inventory (184,800) (238,094)
Prepaid expenses and other assets (56,699) (10,087)
Payables, accrued expenses and other liabilities 59,305 161,251
Operating lease liabilities (177,183) (172,575)
Net cash (used in) provided by operating activities (6,170) 222,279
Cash flows from investing activities:    
Cash paid for property and equipment (143,445) (159,008)
Cash paid for marketable securities (22,000) (442,249)
Sales and maturities of marketable securities 230,745 237,879
Net cash provided by (used in) investing activities 65,300 (363,378)
Cash flows from financing activities:    
Proceeds from the exercise of stock options 376 2,815
Share repurchases related to share repurchase program (112,016) (14,888)
Share repurchases related to taxes for share-based awards (6,680) (7,684)
Net cash used in financing activities (118,320) (19,757)
Effect of exchange rate changes on cash and cash equivalents 46 1,575
(Decrease) increase in cash and cash equivalents (59,144) (159,281)
Cash and cash equivalents at beginning of period 206,575 395,635
Cash and cash equivalents at end of period 147,431 236,354
Cash paid during the year for:    
Income taxes 33,516 81,747
Non-cash investing activities—Accrued capital expenditures $ 41,431 $ 75,206